Bringing the fundamentals into focus…
Back to Climb Bio, Inc.
How Climb Bio, Inc. stacks up
CLYM · against 557 other Healthcare companies listed in US-listed
Profitability
21/ 100
Below the middle of the pack.
Ranked #323 of 558 · scores higher than 40% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including CLYM · Click a bar to see the companies
Why profitability scores 21?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 83% of peers. Return on assets: -23.4% vs peer median 1.7%
- a lower return on invested capital: weaker than 81% of peers. Return on invested capital: -26.2% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = CLYM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CLYM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -26.2% | -7.0% | 37% | 33% | |
| Operating marginHigher is better · 479 reported | Not reported | -2.4% | — | — | 33% |
| Return on assetsHigher is better · 582 reported | -23.4% | -7.8% | 35% | 33% | |
| Return on equityHigher is better · 531 reported | -27.1% | -19.7% | 45% | Context only | |
| Gross marginHigher is better · 601 reported | 0.0% | 43.9% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CLYM| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 312 | 394M USD | 22 | 37 | |
| 312 | 2.0B USD | 22 | 29 | |
| 323 | 8.4B USD | 21 | 28 | |
| 323 | 7.3B USD | 21 | 32 | |
| 323 | 560M USD | 21 | 42 | |
| 323 | 365M USD | 21 | 41 | |
| 323 | 486M USD | 21 | 16 | |
| 323 | 375M USD | 21 | 46 | |
| 323 | 285M USD | 21 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score